Table 3.
Laboratory findings
| Group 1 N = 58 | Group 2 N = 219 | P | Group 1 N = 58 | Group 2A N = 156 | Group 2b N = 63 | P | |
|---|---|---|---|---|---|---|---|
| Leukocytes (103/mm3) | 14.5 ± 4.8 | 13.9 ± 5.6 | 0.6 | 14.5 ± 4.8 | 14.2 ± 6.0 | 13.2 ± 5.0 | 0.6 |
| Erythrocytes (106/mm3) | 4.5 ± 0.5 | 4.5 ± 0.6 | 0.9 | 4.5 ± 0.5 | 4.5 ± 0.6 | 4.5 ± 0.8 | 0.9 |
| Hemoglobin (g/dL) | 14.5 ± 1.3 | 13.9 ± 1.6 | 0.4 | 14.5 ± 1.3 | 14.2 ± 3.0 | 13.4 ± 2.4 | 0.4 |
| Hematocrit (%) | 42 ± 5 | 41 ± 5 | 0.5 | 42 ± 5 | 41 ± 5 | 40 ± 5 | 0.5 |
| Platelet count (103/mm3) | 228 ± 66 | 217 ± 70 | 0.7 | 228 ± 66 | 219 ± 63 | 212 ± 82 | 0.9 |
| Admission glycemia (mmol/l) | 9.7 ± 2.7 | 9.3 ± 3.8 | 0.7 | 9.7 ± 2.7 | 9.4 ± 3.9 | 9.1 ± 3.8 | 0.4 |
| Total cholesterol (mmol/l) | 4.7(4.4–5.8) | 5.7(4.9–7.1) | 0.01 | 4.7(4.4–5.8) | 6.0(4.8–7.3) | 5.6(5.0–6.6) | 0.02 |
| HDL cholesterol (mmol/l) | 1.4(1.1–1.7) | 1.3(1.1–1.6) | 0.8 | 1.4(1.1–1.7) | 1.4(1.0–1.7) | 1.2(1.1–1.6) | 0.6 |
| LDL cholesterol (mmol/l) | 3.0(2.5–3.9) | 4.2(3.2–4.6) | 0.01 | 3.0(2.5–3.9) | 4.6(3.6–5.0) | 3.9(3.2–4.6) | 0.02 |
| Triglycerides (mmol/l) | 1.1(0.8–1.7) | 1.2(0.9–1.8) | 0.7 | 1.1(0.8–1.7) | 1.1(0.8–1.7) | 1.3(0.9–1.9) | 0.5 |
| Serum creatinine (μmol/l) | 83(76–101) | 89(77–114) | 0.5 | 83(76–101) | 86 (77–99) | 84(76–108) | 0.3 |
| eGFR (ml/min per 1.73 m2) | 75(67–87) | 70(60–85) | 0.4 | 75(67–87) | 72(62–87) | 69(50–80) | 0.9 |